Response by Lee and Stouffer to Letter Regarding Article, “Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.